Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

OABI

OmniAb (OABI)

OmniAb Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:OABI
日付受信時刻ニュースソース見出しコード企業名
2024/06/0420 : 20Business WireOmniAbが重鎖単一ドメイン抗体ニワトリプラットフォームに関する学術論文を米国免疫学会雑誌に発表NASDAQ:OABIOmniAb Inc
2024/06/0405 : 05Business WireOmniAb Announces Publication of Scientific Paper on Heavy Chain-Only Single-Domain Antibody Chicken Platform in the Journal of ImmunologyNASDAQ:OABIOmniAb Inc
2024/05/2021 : 05Business WireOmniAb to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:OABIOmniAb Inc
2024/05/1605 : 05Business WireOmniAb Presents High-Throughput Single B-cell Screening xPloration® Data at the 20th Annual PEGS Boston SummitNASDAQ:OABIOmniAb Inc
2024/05/1005 : 05Business WireOmniAb Reports First Quarter 2024 Financial Results and Business HighlightsNASDAQ:OABIOmniAb Inc
2024/05/0121 : 00Business WireOmniAb to Participate in Five Investor Conferences in MayNASDAQ:OABIOmniAb Inc
2024/04/2221 : 00Business WireOmniAb to Report First Quarter 2024 Financial Results on May 9NASDAQ:OABIOmniAb Inc
2024/03/2105 : 05Business WireOmniAb Reports Fourth Quarter and Full Year 2023 Financial Results and Business HighlightsNASDAQ:OABIOmniAb Inc
2024/02/2622 : 00Business WireOmniAb to Report Fourth Quarter 2023 Financial Results on March 20NASDAQ:OABIOmniAb Inc
2024/02/2022 : 00Business WireOmniAb to Participate in Two Investor Conferences in MarchNASDAQ:OABIOmniAb Inc
2023/12/1506 : 30Business WireOmniAb Presents New Scientific Data on its OmnidAb™ Platform at the 2023 Antibody Engineering & Therapeutics ConferenceNASDAQ:OABIOmniAb Inc
2023/11/1007 : 55Business WireOmniAb Highlights OmnidAb™ Launch and its Expanding Drug Discovery Platform at Today’s Research & Technology Virtual EventNASDAQ:OABIOmniAb Inc
2023/11/0922 : 00Business WireOmniAb Reports Third Quarter 2023 Financial Results and Business HighlightsNASDAQ:OABIOmniAb Inc
2023/11/0221 : 00Business WireOmniAb to Participate in Two Investor Conferences in NovemberNASDAQ:OABIOmniAb Inc
2023/11/0122 : 00Business WireOmniAb Appoints Steve Love to its Board of DirectorsNASDAQ:OABIOmniAb Inc
2023/11/0105 : 28Business WireOmniAb Announces Agenda for its Research & Technology Virtual EventNASDAQ:OABIOmniAb Inc
2023/10/1221 : 00Business WireOmniAb to Hold Research & Technology Virtual Event on November 9NASDAQ:OABIOmniAb Inc
2023/09/0521 : 00Business WireOmniAb to Participate in Two Investor Conferences in SeptemberNASDAQ:OABIOmniAb Inc
2023/08/1105 : 05Business WireOmniAb Reports Second Quarter 2023 Financial Results and Business HighlightsNASDAQ:OABIOmniAb Inc
2023/08/0805 : 05Business WireOmniAb Announces the Passing of Director Sunil PatelNASDAQ:OABIOmniAb Inc
2023/07/3121 : 00Business WireOmniAb to Report Second Quarter 2023 Financial Results on August 10NASDAQ:OABIOmniAb Inc
2023/05/1805 : 05Business WireOmniAb Launches OmniDeep™ at the PEGS Boston Conference and ExpoNASDAQ:OABIOmniAb Inc
2023/05/1120 : 00Business WireOmniAb Reports First Quarter 2023 Financial Results and Business HighlightsNASDAQ:OABIOmniAb Inc
2023/05/0121 : 00Business WireOmniAb to Report First Quarter 2023 Financial Results on May 11NASDAQ:OABIOmniAb Inc
2023/04/2521 : 00Business WireOmniAb to Participate in Upcoming Investor Conferences in MayNASDAQ:OABIOmniAb Inc
2023/03/3105 : 05Business WireOmniAb Reports Fourth Quarter and Full Year 2022 Financial Results and Business HighlightsNASDAQ:OABIOmniAb Inc
2023/03/0922 : 00Business WireOmniAb to Report Fourth Quarter 2022 Financial Results on March 30NASDAQ:OABIOmniAb Inc
2023/02/0722 : 00Business WireOmniAb to Participate in Three Upcoming Investor ConferencesNASDAQ:OABIOmniAb Inc
2022/12/0122 : 47GlobeNewswire Inc.Hillstream BioPharma Announces Development of Proprietary Targeted Biologics, Knob Quatrabodies™ (HSB-1940) against PD-1, by combining Quatramers™ with OmniAb’s Picobodies™, via a Collaboration Agreement, against Novel, Unreachable and UndruggableNASDAQ:OABIOmniAb Inc
2022/11/1521 : 13Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OABIOmniAb Inc
 Showing the most relevant articles for your search:NASDAQ:OABI

最近閲覧した銘柄

Delayed Upgrade Clock